e-learning
resources
Munich 2006
Monday 04.09.2006
Diagnosis and treatment in community-acquired pneumonia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
CRP and ESR as discharged criteria of patients admitted with community-acquired pneumonia
M. B. Ramadan (Tripoli, Libyan Arab Jamahiriya)
Source:
Annual Congress 2006 - Diagnosis and treatment in community-acquired pneumonia
Session:
Diagnosis and treatment in community-acquired pneumonia
Session type:
Electronic Poster Discussion
Number:
2229
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. B. Ramadan (Tripoli, Libyan Arab Jamahiriya). CRP and ESR as discharged criteria of patients admitted with community-acquired pneumonia. Eur Respir J 2006; 28: Suppl. 50, 2229
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Admission CRP and D-dimer levels can identify high-risk patients with community-acquired pneumonia
Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity
Year: 2010
Differential characteristics in elderly patients with community-acquired pneumonia (CAP) who required admission to ICU
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009
Inflammatory biomarkers in predicting ICU admission of severe community-acquired pneumonia (CAP)
Source: Annual Congress 2011 - Pulmonary infections and sepsis
Year: 2011
Pro-adrenomedullin, procalcitonin and CRP levels to predict bacterial pneumonia in patients admitted to emergency room
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011
Calprotectin as a biomarker of pneumonia in patients hospitalized with AECOPD
Source: International Congress 2019 – Airway infection in COPD
Year: 2019
Severe community-acquired pneumonia (CAP): validation of the IDSA/ATS guidelines to predict admission to the ICU
Source: Annual Congress 2008 - Diagnosis and outcome in critically ill patients
Year: 2008
Criteria for clinical stability in hospitalised patients with community-acquired pneumonia
Source: Eur Respir J 2013; 42: 742-749
Year: 2013
Risk factors in readmission of patients with community-acquired pneumonia discharged from the emergency department
Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections
Year: 2012
Comparison of clinical characteristics between healthcare-associated pneumonia and community-acquired pneumonia in patients admitted into secondary hospitals
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012
Is severity index enough to assess hospital admission of community-acquired pneumonia (CAP) patients?
Source: Annual Congress 2006 - Evaluation of risk factors in community-acquired pneumonia
Year: 2006
The influence of prednisolone on C-reactive protein and procalcitonin in patients hospitalised with community-acquired pneumonia
Source: Annual Congress 2010 - Risk factors and outcomes in community-acquired pneumonia
Year: 2010
Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia
Source: Eur Respir J 2006; 27: 1210-1216
Year: 2006
Steroids are not associated with an improvement in clinical outcomes in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections
Year: 2009
Diagnostic and prognostic value of C-reactive protein in community-acquired pneumonia hospitalized patients
Source: Eur Respir J 2004; 24: Suppl. 48, 188s
Year: 2004
An unbalanced inflammatory response on admission impacts clinical stability in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011
Predictive factors of length of hospital stay in patients admitted with community-acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 375s
Year: 2006
Lactate is an independent marker of severity in hospitalised patients with community-acquired pneumonia
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011
Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia
Source: Eur Respir J 2008; 32: 726-732
Year: 2008
On improving assessment of in-hospital mortality and ICU admisison in community-acquired pneumonia patients by using the e-CURB
Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome
Year: 2012
Early admission predictors in COPD patients admitted at hospital for an exacerbation
Source: Annual Congress 2010 - COPD exacerbation
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept